Search results
Results from the WOW.Com Content Network
The primary outcome of the VEST-study, arrhythmic mortality, was 1.6% in the WCD group vs. 2.4% in the control group. The difference was not significant despite a 33% relative risk reduction (RRR). The secondary outcome of the VEST-study, all-cause mortality, was 3.1% in the WCD group and 4.9% in the control group.
For premium support please call: 800-290-4726 more ways to reach us
The AutoPulse is an automated, portable, battery-powered cardiopulmonary resuscitation device created by Revivant and subsequently purchased and currently manufactured by ZOLL Medical Corporation. It is a chest compression device composed of a constricting band and half backboard that is intended to be used as an adjunct to CPR during advanced ...
For premium support please call: 800-290-4726 more ways to reach us
Paul Maurice Zoll (July 15, 1911 – January 5, 1999) [1] was a Jewish [2] American cardiologist and one of the pioneers in the development of the artificial cardiac pacemaker and cardiac defibrillator.
For premium support please call: 800-290-4726 more ways to reach us
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Help; Learn to edit; Community portal; Recent changes; Upload file